tooluniverse-nih-funding-landscape
Installation
SKILL.md
NIH Funding Landscape
Build source-traceable NIH funding analyses with explicit scopes, count units, data coverage, and interpretation limits. Use OpenNIH_* for funding facts and other ToolUniverse sources only for downstream evidence they actually cover.
Always read references/tool-reference.md before choosing tools or comparing totals. Read references/verified-cases.md when testing the skill, debugging an unexpected response, or adapting one of the verified case patterns. Read references/public-value-cases.md for a patient, family, advocate, journalist, trainee, applicant, taxpayer, policy, or other public-facing request.
Public Value Routing
Start from the reader's decision, not from the available endpoints:
| Reader | Optimize the answer for | Never imply |
|---|---|---|
| Patient, family, advocate | A topic-specific research map, recent activity, inspectable projects, and next contacts | Clinical expertise, quality of care, treatment advice, or patient benefit from funding alone |
| Journalist, taxpayer, policy analyst | A reproducible headline number, its definition, its largest drivers, and its sensitivity to alternate queries | That the largest number is the truest, a partial year is final, or spending caused outcomes |
| Researcher, trainee, applicant | Funded precedents, active mechanisms, institutions, and project language | Application odds, reviewer preferences, mentorship quality, or K99-to-R00 conversion |
| Institution or translational team | Resolved peer portfolios and exact identifiers for output follow-up | Raw-name totals as one entity or grant-output chronology as causality |
| Local reporter or community | A location-qualified portfolio joined through resolved institutions | That an institution-name substring is a city/state geography query or that award location equals beneficiary location |
| Entrepreneur | Topic-specific R41/R42/R43/R44 awards, companies, and phase-labeled project activity | Commercial success, current company status, addressable market, or Phase I-to-II conversion from annual award rows |